NO20000016L - Sykliske azapeptider med angiogen virkning - Google Patents

Sykliske azapeptider med angiogen virkning

Info

Publication number
NO20000016L
NO20000016L NO20000016A NO20000016A NO20000016L NO 20000016 L NO20000016 L NO 20000016L NO 20000016 A NO20000016 A NO 20000016A NO 20000016 A NO20000016 A NO 20000016A NO 20000016 L NO20000016 L NO 20000016L
Authority
NO
Norway
Prior art keywords
angiogenic activity
aarg
aasp
agly
azapeptides
Prior art date
Application number
NO20000016A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000016D0 (no
Inventor
Alfred Jonczyk
Simon Goodman
Horst Kessler
Jochen Wermuth
Joerg Schmitt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20000016D0 publication Critical patent/NO20000016D0/no
Publication of NO20000016L publication Critical patent/NO20000016L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20000016A 1997-07-04 2000-01-03 Sykliske azapeptider med angiogen virkning NO20000016L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19728524A DE19728524A1 (de) 1997-07-04 1997-07-04 Cyclische Azapeptide
PCT/EP1998/003955 WO1999001472A1 (de) 1997-07-04 1998-06-29 Cyclische azapeptide mit angiogener wirkung

Publications (2)

Publication Number Publication Date
NO20000016D0 NO20000016D0 (no) 2000-01-03
NO20000016L true NO20000016L (no) 2000-01-03

Family

ID=7834596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000016A NO20000016L (no) 1997-07-04 2000-01-03 Sykliske azapeptider med angiogen virkning

Country Status (20)

Country Link
US (1) US6534478B1 (id)
EP (1) EP1001979B1 (id)
JP (1) JP2002511872A (id)
KR (1) KR20010014267A (id)
CN (1) CN1261895A (id)
AR (1) AR010924A1 (id)
AT (1) ATE297947T1 (id)
AU (1) AU733831B2 (id)
BR (1) BR9810394A (id)
CA (1) CA2297181A1 (id)
DE (2) DE19728524A1 (id)
HU (1) HUP0003357A3 (id)
ID (1) ID23415A (id)
NO (1) NO20000016L (id)
PL (1) PL337616A1 (id)
RU (1) RU2188205C2 (id)
SK (1) SK173599A3 (id)
TW (1) TW482768B (id)
WO (1) WO1999001472A1 (id)
ZA (1) ZA985896B (id)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71608C2 (en) 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
DE60027718T2 (de) 1999-06-22 2007-05-16 Takeda Pharmaceutical Co. Ltd. Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
GB0217017D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 2
WO2008033557A2 (en) * 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclic peptidomimetics as integrin markers
WO2009018175A2 (en) * 2007-07-27 2009-02-05 Siemens Medical Solutions Usa, Inc. Cyclic azapeptides as integrin markers
US8133472B2 (en) 2008-04-30 2012-03-13 Siemens Medical Solutions Usa, Inc. Cyclopeptides containing RGD mimetics as imaging markers for integrins
US8293206B2 (en) 2008-05-30 2012-10-23 Siemens Medical Solutions Usa, Inc. Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment
CA2665302A1 (en) * 2009-05-01 2010-11-01 Universite De Montreal Cd36 modulation and uses thereof
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648224B1 (en) * 1992-06-04 1998-07-15 Merrell Pharmaceuticals Inc. Conformationally restrained peptide analogs as antiplatelet agents
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
AU1975695A (en) * 1994-03-04 1995-09-18 Du Pont Merck Pharmaceutical Company, The Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
US5858972A (en) * 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
DE19653036A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate

Also Published As

Publication number Publication date
JP2002511872A (ja) 2002-04-16
ID23415A (id) 2000-04-20
WO1999001472A1 (de) 1999-01-14
AU8541198A (en) 1999-01-25
EP1001979A1 (de) 2000-05-24
HUP0003357A3 (en) 2001-12-28
TW482768B (en) 2002-04-11
EP1001979B1 (de) 2005-06-15
HUP0003357A2 (hu) 2001-02-28
AR010924A1 (es) 2000-07-12
ZA985896B (en) 1999-06-14
DE19728524A1 (de) 1999-01-07
AU733831B2 (en) 2001-05-24
CA2297181A1 (en) 1999-01-14
SK173599A3 (en) 2000-06-12
ATE297947T1 (de) 2005-07-15
PL337616A1 (en) 2000-08-28
BR9810394A (pt) 2000-09-05
US6534478B1 (en) 2003-03-18
NO20000016D0 (no) 2000-01-03
KR20010014267A (ko) 2001-02-26
DE59812870D1 (de) 2005-07-21
RU2188205C2 (ru) 2002-08-27
CN1261895A (zh) 2000-08-02

Similar Documents

Publication Publication Date Title
NO986090L (no) Fenylalaninderivater som integrininhibitorer
TW372232B (en) Phenylalanine derivatives
TR200201059T2 (tr) Kardiyak arritmialarının tedavisinde kullanışlı yeni oksabispidin bileşimleri
ATE93236T1 (de) Acylatiertes uridin und cytidin und deren verwendungen.
BR9912072A (pt) Derivados diacil-hidrazina
BR9807345A (pt) Aminoácidos aromáticos biciclicos.
NO20000016L (no) Sykliske azapeptider med angiogen virkning
NO20002702L (no) Tienopyrimidiner
SE8304737D0 (sv) Karbostyrilderivat
KR900700435A (ko) 신규아민류 및 그 용도
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
MY136788A (en) 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment or cardiac arrhythmias
CA2348391A1 (en) Chromenone and chromanone derivatives as integrin inhibitors
ATE427107T1 (de) Eine neue verwendung von deferiprone
MXPA02008213A (es) Compuestos piperazina sustituidos.
NO20020131L (no) Diacylhydrazinderivater
CA2185394A1 (en) Biotinderivate
SE0003795D0 (sv) Pharmaceutically useful compounds
NO20000860L (no) Syklopeptidderivater som adhesjonsinhibitorer
WO2005063807A3 (en) Treatment of coronary or peripheral ischemia
SE9902268D0 (sv) Pharmaceutically active compounds
SE9902270D0 (sv) Pharmaceutically active compounds
NO20020592L (no) Fluorenderivater som integrininhibitorer
SE9902271D0 (sv) Pharmaceutically active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application